跳至主要内容
临床试验/DRKS00015617
DRKS00015617已完成不适用

Evaluation of fetotoxicity after 2nd and 3rd trimester exposure to NSAID, metamizole, acetylsalicylic acid and paracetamol - Fetotoxicity of NSAID

Pharmakovigilanzzentrum Embryonaltoxikologie, Charité Universitätsmedizin Berlin0 个研究点目标入组 4,000 人开始时间: 2018年11月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,000

研究概览

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
Female

入选标准

  • These criteria apply for the exposed and comparison cohorts:
  • Prospective case reports ascertained and archived in the database of the German Embryotox Pharmacovigilance Centre. Prospectively ascertainment means that neither pregnancy outcome was known nor prenatal pathology had been diagnosed at the time our institute was contacted. Follow-up of pregnancy outcome including relevant data on the infant.
  • Data analysis will be based on documented cases exposed to the study medication archived in the database of the Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy (2008-2017).

排除标准

  • Retrospective case reports

研究者

发起方
Pharmakovigilanzzentrum Embryonaltoxikologie, Charité Universitätsmedizin Berlin

相似试验